InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Yilmaz Mahshid, 首席财务官. Insider active across 1 company, notably Egetis Therapeutics AB (publ). Aggregated, 4 filings have been recorded. History available since 26 November 2025. The latest transaction was filed on 11 May 2026 (Purchase). Regulator: FIN-FSA. All data is free.
Companies and markets linked to Yilmaz Mahshid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
153,631 股@ SEK 6.500.0037% mcap44.8% 占其流量AktieISIN SE0003815604FI:csv-fd45067293b119868f0a
264,880 股0AktieISIN SE0003815604FI:csv-20298035c5d4dc97dbf5
153,631 股@ SEK 6.500.0043% mcap81.3% 占其流量AktieISIN SE0003815604FI:A003Y582-1
60,000 股@ €0.35090.0010% mcap18.7% 占其流量AktieISIN SE0003815604FI:A003U276-2
4 条申报中的 4 条
About Yilmaz Mahshid
Yilmaz Mahshid is the Chief Financial Officer of Egetis Therapeutics AB (publ). In this role, he is responsible for the financial management of the company, including budgeting and financial analysis. His expertise is essential to ensure the financial health of the organization.
